Doximity, Inc. (NASDAQ:DOCS - Get Free Report) Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $52.89, for a total transaction of $105,780.00. Following the completion of the sale, the director now directly owns 16,618 shares of the company's stock, valued at $878,926.02. This trade represents a 10.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Kira Scherer Wampler also recently made the following trade(s):
- On Monday, June 2nd, Kira Scherer Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $52.89, for a total transaction of $105,780.00.
- On Thursday, May 1st, Kira Scherer Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00.
Doximity Stock Performance
Shares of DOCS traded up $2.69 during midday trading on Thursday, hitting $57.26. 2,713,313 shares of the stock traded hands, compared to its average volume of 2,115,677. Doximity, Inc. has a 1-year low of $25.00 and a 1-year high of $85.21. The firm has a market capitalization of $10.75 billion, a PE ratio of 57.26, a price-to-earnings-growth ratio of 4.10 and a beta of 1.32. The business's 50 day moving average price is $54.70 and its two-hundred day moving average price is $58.08.
Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the prior year, the business earned $0.25 earnings per share. The company's quarterly revenue was up 17.1% on a year-over-year basis. As a group, equities research analysts forecast that Doximity, Inc. will post 0.99 EPS for the current fiscal year.
Institutional Investors Weigh In On Doximity
Hedge funds and other institutional investors have recently modified their holdings of the stock. Global Retirement Partners LLC raised its stake in shares of Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after purchasing an additional 440 shares in the last quarter. VSM Wealth Advisory LLC bought a new stake in shares of Doximity during the first quarter valued at about $29,000. Allworth Financial LP raised its stake in shares of Doximity by 104.0% during the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI bought a new stake in shares of Doximity during the first quarter valued at about $33,000. Finally, Spire Wealth Management raised its stake in shares of Doximity by 73.2% during the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on DOCS shares. Truist Financial lowered their price objective on shares of Doximity from $58.00 to $52.00 and set a "hold" rating for the company in a research report on Friday, May 16th. Raymond James lowered their price objective on shares of Doximity from $83.00 to $65.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. Morgan Stanley reduced their target price on Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research note on Thursday, April 24th. Finally, Mizuho reduced their target price on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a research note on Friday, May 16th. Eleven investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, Doximity has an average rating of "Moderate Buy" and a consensus target price of $62.84.
Check Out Our Latest Research Report on DOCS
Doximity Company Profile
(
Get Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.